Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.

Xenobiotica; the fate of foreign compounds in biological systems·2009

Same author

Determination of the CYP2B6 component of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activity in human liver microsomes.

Methods in molecular biology (Clifton, N.J.)·2003

Same author

High-performance liquid chromatographic analysis of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation.

Methods in molecular biology (Clifton, N.J.)·2003

Same author

Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography.

Methods in molecular biology (Clifton, N.J.)·2003

Same author

CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.

Methods in molecular biology (Clifton, N.J.)·2003

Same author

CYP2D6-dependent bufuralol 1'-hydroxylation assayed by reversed-phase ion-pair high-performance liquid chromatography with fluorescence detection.

Methods in molecular biology (Clifton, N.J.)·2003

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Higher-throughput screening with human cytochromes P450.

¹Gentest Corp, Woburn, MA 01801, USA. crespi@gentest.com

Current Opinion in Drug Discovery & Development

|August 4, 2009

Summary

This summary is machine-generated.

Drug metabolism studies using cytochrome P450 enzymes are faster and more efficient. Innovations include measuring multiple analytes simultaneously and using fluorometric assays for drug interaction screening.

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Related Experiment Videos

Last Updated: Jun 21, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Area of Science:

Pharmacology
Drug Metabolism
Preclinical Studies

Background:

Cytochrome P450 enzymes play a crucial role in drug metabolism.
Accurate and efficient measurement of drug metabolism is vital in preclinical drug development.
Drug-drug interactions mediated by cytochrome P450 enzymes can lead to adverse effects.

Purpose of the Study:

To review recent innovations for increasing throughput in cytochrome P450 metabolism assays.
To highlight methods for reducing sample numbers and improving efficiency in drug candidate screening.
To discuss advancements in identifying potential drug-drug interactions.

Main Methods:

Simultaneous measurement of multiple analytes in a single High-Performance Liquid Chromatography (HPLC) injection.
Development and application of fluorometric assays for screening cytochrome P450 inhibition.
Review of established and novel techniques in preclinical drug metabolism studies.

Main Results:

Simultaneous analysis significantly reduces sample requirements for HPLC-based assays.
Fluorometric assays provide a high-throughput method for screening drug-drug interaction mechanisms.
Both innovations lead to substantial increases in experimental throughput.
Resource requirements for routine preclinical studies are decreased.

Conclusions:

Technological advancements are enhancing the efficiency of drug metabolism and interaction studies.
These innovations streamline preclinical drug development processes.
Reduced resource utilization enables faster screening of drug candidates.